Susan C Lin

US Patent:

7403575, Jul 22, 2008

Filed:

Feb 20, 2003

Appl. No.:

10/371074

Inventors:

Stephan W. Gehring - Menlo Park CA, US
Jason L. Ellis - San Diego CA, US
Susan C. Lin - San Diego CA, US
Gerald D. Rogerson - Poway CA, US

Assignee:

General Atomics - San Diego CA

International Classification:

H04L 27/30

US Classification:

375308

Abstract:

A method and apparatus for operation in a multi-frequency band wideband system in the presence of an interference, the method comprising the steps: receiving signaling in a plurality of wideband frequency sub-bands, each wideband frequency sub-band having a different center frequency, wherein a bandwidth of each wideband frequency sub-band is at least 2 percent of a center frequency of the wideband frequency sub-band; detecting an interfering signal having signal energy in a portion of a respective sub-band of the wideband frequency sub-bands; modifying at least one of a center frequency and a bandwidth of the respective sub-band in order to operate in the presence of the interfering signal; and instructing a transmitting device transmitting the signaling to transmit subsequent signaling accounting for the modification of the center frequency of the respective sub-band.

US Patent:

20040048574, Mar 11, 2004

Filed:

Feb 20, 2003

Appl. No.:

10/371064

Inventors:

Michael Walker - San Diego CA, US
David Furuno - San Diego CA, US
Stephan Gehring - Menlo Park CA, US
Gerald Rogerson - Poway CA, US
Susan Lin - San Diego CA, US

Assignee:

General Atomics - San Diego CA

International Classification:

H04B015/00

US Classification:

455/063100

Abstract:

A method and apparatus for operation in a multi-frequency band system in the presence of an interference, the method comprising the steps of: receiving signaling in a plurality of wideband frequency sub-bands, each wideband frequency sub-band having a different center frequency, wherein a bandwidth of each wideband frequency sub-band is at least 2 percent of a center frequency of the wideband frequency sub-band; detecting an interfering signal having signal energy in a portion of a respective sub-band of the wideband frequency sub-bands; deciding to discontinue use of the respective sub-band; and instructing a transmitting device transmitting the signaling to transmit subsequent signaling in any except the respective sub-band of the plurality of wideband frequency sub-bands.

US Patent:

20210340238, Nov 4, 2021

Filed:

Jul 11, 2019

Appl. No.:

17/258908

Inventors:

- Cambridge MA, US
Thomas Schurpf - Cambridge MA, US
Allan Capili - Somerville MA, US
Stefan Wawersik - Westborough MA, US
Christopher Chapron - Watertown MA, US
Christopher Littlefield - Marblehead MA, US
Gregory J. Carven - Maynard MA, US
Kevin B. Dagbay - Brighton MA, US
Susan Lin - Boston MA, US
Justin W. Jackson - Cambridge MA, US
Caitlin Stein - Lebanon NH, US

International Classification:

C07K 16/22
A61P 13/12

Abstract:

Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1. Related compositions, methods and therapeutic use are also disclosed.

US Patent:

20210122814, Apr 29, 2021

Filed:

Jul 11, 2019

Appl. No.:

17/258771

Inventors:

- Cambridge MA, US
Allan Capili - Somerville MA, US
Thomas Schurpf - Cambridge MA, US
Constance Martin - Arlington MA, US
Kevin B. Dagbay - Brighton MA, US
Christopher Chapron - Watertown MA, US
Stefan Wawersik - Westborough MA, US
Christopher Littlefield - Marblehead MA, US
Gregory J. Carven - Maynard MA, US
Alan Buckler - Arlington MA, US
Susan Lin - Boston MA, US
Justin W. Jackson - Cambridge MA, US
Caitlin Stein - Lebanon NH, US
Andrew Avery - Lebanon NH, US
Anthony Cooper - White River Junction VT, US
Matthew Salotto - Hanover NH, US

International Classification:

C07K 16/22
A61K 45/06
A61P 35/00

Abstract:

Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.

US Patent:

20200079840, Mar 12, 2020

Filed:

Jul 11, 2019

Appl. No.:

16/509068

Inventors:

- Cambridge MA, US
Allan Capili - Somerville MA, US
Thomas Schurpf - Cambridge MA, US
Constance Martin - Arlington MA, US
Kevin B. Dagbay - Brighton MA, US
Christopher Chapron - Watertown MA, US
Stefan Wawersik - Westborough MA, US
Christopher Littlefield - Marblehead MA, US
Gregory J. Carven - Maynard MA, US
Alan Buckler - Arlington MA, US
Susan Lin - Boston MA, US
Justin W. Jackson - Cambridge MA, US

International Classification:

C07K 16/22
A61P 13/12
A61P 1/16
A61P 35/00
A61K 49/00
A61K 45/06
A61K 39/395
C07K 16/28

Abstract:

Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.